Sectra acquires digital detector maker Mamea , sells wireless information systems to Axentia

Sectra AB has completed its acquisition of Mamea Imaging AB. The company this week also sold the operations of DARC wireless information systems within Sectra Wireless Technologies AB to Axentia Technologies AB.

The Swedish IT company this week acquired 5,260 shares in Mamea from Life Equity Sweden KB. Sectra says the acquisition has no material effect on its earnings and financial position.

"As a result of the acquisition, we have completed the alignment of the ownership structure in Mamea Imaging AB," said Jan-Olof Brüer, CEO and President of Sectra AB. "The acquisition of Mamea is part of our increased focus on the mammography market, where our aim is to become established as a leading player with our mammography screening system, Sectra MicroDose Mammography."

Mamea was founded in 1999 by a research group at the Royal Institute of Technology in Stockholm and Sectra. The company has developed a new type of digital radiology detector that combines high image quality with minimal radiation dosage.

Concurrent with the Sectra-Axentia agreement, the new owner will further develop these operations for existing and new customers. Axentia is owned by a group of five former Sectra personnel.

Sectra says its Wireless Technologies' operations accounted for less than 1 percent of consolidated sales in FY 03/04 and the divestment of these operations will not have any significant impact on Sectra's earnings or financial position. The contract includes a supplemental purchase price, whereby Sectra says it will receive a percentage of any profit reported by Axentia during the next five years.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Trimed Popup
Trimed Popup